The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Kinetics of Circulating Tumoral Cells in Bronchial Primitive Cancer
Official Title: Kinetics of Circulating Tumoral Cells in Bronchial Primitive Cancer
Study ID: NCT03328559
Brief Summary: The pronostic value of Circulating Tumoral Cells(CTC) 's dosage by the method ISET® (tumoral cell isolation by size) in patients with bronchial cancer was previously demonstrated. However, no kinetic study was ever realized to study the value of the CTC as predictive indicator of answer to the therapy. This project plans to study patients in an early stage and patients at advance stage locally moved forward or metastatic of the disease by evaluation of the presence and the number of CTC before every cure. This collaborative and original study should allow to refine the diagnoses of answer and to plan the possible relapses what would allow a premature institution of the treatment.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Groupe Hospitalier Paris Saint Joseph, Paris, Ile-de-France, France
Name: Jean P Tredaniel, Pr
Affiliation: Fondation Hôpital Saint-Joseph
Role: PRINCIPAL_INVESTIGATOR